From what I've read that is not necessarily the case.
Who is eligible to receive monoclonal antibody therapy?
________________________________
If you are on Medicare they will cover at-home infusion treatment (if certain criteria are met, of course):
Payment for Infusion at Home Beginning on May 6, 2021, Medicare established separate coding and payment for administering COVID-19 monoclonal antibody products in a patient’s home or residence. Effective for services furnished on or after May 6, 2021, the Medicare payment rate for administering monoclonal antibody products in a patient’s home or residence is approximately $750. This rate reflects updated information about the costs involved in furnishing these complex products in a patient’s home. For many providers and suppliers, CMS also geographically adjusts this rate based on where you furnish the service.
Excerpted, more info at link:
https://www.cms.gov/medicare/covid-19/monoclonal-antibody-covid-19-infusion
_______________________________
IIRC Medicare coverage doesn’t start till 65.
What do folks between 60 and 65 do?
From the link, here are the criteria:
“Who is eligible to receive monoclonal antibody therapy?
Monoclonal antibody treatment is available to individuals who:
Are high risk** for developing severe COVID-19 and
Have a positive COVID-19 test and have not yet been admitted to the hospital and
Are 12 years of age or older (and at least 88 pounds)
Post-exposure preventive monoclonal antibodies are available to those who have been exposed (consistent with the CDC’s close contact criteria)* and who are:
High risk** for developing severe COVID-19 and
12 years of age or older (and at least 88 pounds) and
Not fully vaccinated or vaccinated but immunocompromised
*In some cases, direct exposure isn’t a criterion. If you meet the criteria above and are at high risk of exposure to an individual infected because of an occurrence of infection in other individuals in the same institutional setting (for example, nursing homes or prisons), you are eligible for post-exposure preventive monoclonal antibodies.
It is important to understand that post-exposure preventive monoclonal antibodies are not a replacement for vaccination. We highly encourage everyone to get a COVID-19 vaccine.
**High risk includes any of the following:
65 years of age or older
Overweight (body mass index over 25)
Pregnancy
Chronic kidney disease
Diabetes (Type 1 and Type 2)
Weakened immune system
Currently receiving immunosuppressive treatment
Cardiovascular disease/hypertension
Chronic lung disease
Sickle cell disease
Neurodevelopmental disorders
Medical-related technological dependence
“